Edition:
India

People: Church & Dwight Co Inc (CHD.N)

CHD.N on New York Stock Exchange

67.10USD
1:30am IST
Change (% chg)

$0.33 (+0.49%)
Prev Close
$66.77
Open
$66.85
Day's High
$67.42
Day's Low
$66.79
Volume
545,212
Avg. Vol
517,610
52-wk High
$69.47
52-wk Low
$44.88

Vergis, Janet 

Ms. Janet S. Vergis is an Independent Director of Church and dwight co Inc. Ms. Vergis has served as an Executive Advisor for private equity firms since January 2013, where she identifies and evaluates healthcare investment opportunities. From January 2011 to August 2012, she was the Chief Executive Officer of OraPharma, Inc., a specialty pharmaceutical company dedicated to oral health, where she led that company’s successful turnaround and its subsequent sale. From 2004 to 2009, Ms. Vergis served as President of Janssen Pharmaceuticals, McNeil Pediatrics and Ortho-McNeil Neurologics. From 1988 to 2004, she served in various positions of increasing responsibility in executive leadership, research and development, new product development, sales, and marketing with Johnson & Johnson and its subsidiaries.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 110,000
Long-Term Incentive Plans, USD --
All Other, USD 120,000
Fiscal Year Total, USD 230,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Craigie

452,000

Matthew Farrell

6,259,620

Richard Dierker

1,821,720

Britta Bomhard

--

Patrick de Maynadier

1,393,060

Steven Cugine

1,683,280
As Of  31 Dec 2017